Menu
At MediCrops, we are proud of our values and the positive impact they have on our patients and partners. Join our community and experience for yourself how we are revolutionizing the medical cannabis industry.
In an industry that is constantly changing, we are committed to innovation and bold decision-making. Our willingness to take risks and break new ground allows us to provide our patients with the most effective and safe medical cannabis products.
We stand bravely alongside our patients and medical partners. Whether in research or patient care, we spare no challenge to advance the well-being of our customers and push the boundaries of medical cannabis understanding.
Innovation is at the heart of our company culture. Through continuous research and development, we strive to constantly improve therapeutic options for our patients and provide customized solutions.
The health of our patients is our top priority. We rely on transparency, quality controls and scientifically sound methods to gain and maintain the trust of our patients and medical partners.
Fairness is more than a word for us; it is a principle that guides our actions. We are committed to affordable pricing, ethical business practices and respectful communication with all of our stakeholders.
Meet our dynamic management team, the heart of MediCrops. With years of medical and business management experience, they lead our company with vision and expertise. Their common goal: to make medical cannabis safe, efficient and accessible. Each member of our management team brings valuable knowledge and skills that make MediCrops a leader in the industry.
Ivan Mestrangelo, Chairman of the Board of MediCrops Holding AG, is an established entrepreneur and investor with over 15 years of cross-industry expertise. His entrepreneurial career includes successfully founding and scaling companies in the nutraceuticals, longevity, hospitality and construction industries.
In his current role at MediCrops, Ivan focuses on strategically advancing the company in the dynamic medical cannabis market. His extensive experience and business acumen drive the development of innovative business models as well as international expansion.
With a reputation as a visionary leader and skilled strategist, Ivan has established himself as a valued figure in the investment community. His holistic approach to business management and unwavering commitment to entrepreneurial success make him a compelling advocate for the industry.
Eva Vaoutsi, Chief Executive Officer of MediCrops Holding AG, brings over 15 years of experience in multinational companies and start-ups in strategy, digital marketing and sales.
At MediCrops, as CEO, she is largely responsible for managing and developing the company's entrepreneurial activities. Her extensive knowledge of commercial strategy and strategic expansion of companies in the pharmaceutical and medical technology sectors makes her a key figure in the company's continued development. Prior to joining MediCrops, she held senior positions at Neuraxpharm, Baxter Healthcare and other companies in the pharmaceutical and financial sectors.
As a consultant, Eva has helped companies in the pharmaceutical and biotechnology sectors strengthen their commercial strategies, business development and market access strategies.
Eva studied in digital marketing strategies at IMD in Lausanne and holds an MBA from ALBA Graduate Business School in Athens. Working in four different countries, she is fluent in five languages, which has enabled her to create strong connections between different cultural backgrounds.
Our goal is to revolutionize the medical landscape through groundbreaking cannabis therapies. We focus on developing innovative products that meet the needs of our patients. In everything we do, optimizing patient care comes first.
